Current:Home > StocksPhoenix Suns' Kevin Durant out at least two weeks with left calf strain -StockPrime
Phoenix Suns' Kevin Durant out at least two weeks with left calf strain
View
Date:2025-04-25 23:19:15
Phoenix Suns All-star Kevin Durant will be re-evaluated in two weeks after suffering a left calf strain in Friday's 114-113 win over the Dallas Mavericks at American Airlines Center.
Durant was grabbing at his left calf during a timeout before checking into the game with 7:39 remaining. He scored a team-high 26 points in leading Phoenix (8-1) to a seventh straight win.
In Year 18, Durant is averaging 27.6 points on 55.3% shooting as he's hitting 42.9% from three. Posting five 30-point games this season, Durant is also averaging 6.6 rebounds and 3.4 assists this season.
The Suns resume play Sunday against the Sacramento Kings (5-4) at Footprint Center before going on a four-game road trip starting Tuesday at the Utah Jazz (1-7). Based on the injury timetable, Durant will miss the road trip during which the Suns play Utah, Sacramento, Oklahoma City (8-1) and Minnesota (6-3).
Durant missed all five Team USA exhibition games going into the 2024 Paris Olympics with a right calf strain, but returned for the group phase and played in every game during the 6-0 run to gold. He scored 23 points in his return game against Serbia, hitting his first eight shots fueled by a 5-of-5 effort from three.
All things Suns: Latest Phoenix Suns news, schedule, roster, stats, injury updates and more.
He has dealt with a right calf injury in the 2019 playoffs with the Golden State Warriors. He later suffered a right Achilles injury in the NBA Finals that sidelined him for the remainder of the 2019 postseason and the entire 2019-20 season with the Brooklyn Nets.
Have opinions about the current state of the Suns? Reach Suns Insider Duane Rankin at dmrankin@gannett.com or contact him at 480-810-5518. Follow him on X, formerly Twitter, at @DuaneRankin.
veryGood! (9)
Related
- Moving abroad can be expensive: These 5 countries will 'pay' you to move there
- 'Grief is universal': Día de los Muertos honors all dead loved ones. Yes, even pets.
- FDA warns that WanaBana fruit pouches contain high lead levels, endangering children
- Russian-American journalist denied release into house arrest
- Trump issues order to ban transgender troops from serving openly in the military
- What 10 states are struggling the most to hire workers? See map.
- Closing arguments next in FTX founder Sam Bankman’s fraud trial after his testimony ends
- NFL power rankings Week 9: Eagles ascend to top spot after Chiefs' slide
- This was the average Social Security benefit in 2004, and here's what it is now
- A media freedom group accuses Israel and Hamas of war crimes and reports deaths of 34 journalists
Ranking
- What were Tom Selleck's juicy final 'Blue Bloods' words in Reagan family
- New oil leak reported after a ferry that ran aground repeatedly off the Swedish coast is pulled free
- Tyler Christopher, soap opera actor from 'General Hospital' and 'Days of Our Lives,' dead at 50
- Baton Rouge company set to acquire Entergy gas distribution business
- EU countries double down on a halt to Syrian asylum claims but will not yet send people back
- Philadelphia picks winning design for Harriet Tubman statue after controversy over original choice
- At 83, Jack Nicklaus says he plays so poorly now that 'I run out of golf balls'
- 'Grief is universal': Día de los Muertos honors all dead loved ones. Yes, even pets.
Recommendation
House passes bill to add 66 new federal judgeships, but prospects murky after Biden veto threat
Judge rules ex-NFL star Shannon Sharpe did not defame Brett Favre on FS1 talk show
Powerball winning numbers from Oct. 30 drawing: Jackpot now at $152 million
Funeral home gave grieving relatives concrete instead of ashes, man alleges in new lawsuit
McKinsey to pay $650 million after advising opioid maker on how to 'turbocharge' sales
Clemson football's Dabo Swinney stands by response to 'idiot' caller: 'I've never flinched'
Potential cure for sickle cell disease raises few concerns for FDA panel
Pope presses theologians to be in tune with challenges of daily life and talk with non-believers